Free Trial Information
BioCentury | Dec 17, 2012
Company News

Ferrer, Vivia Biotech deal

...developed under the deal, declined to disclose details. Grupo Ferrer Internacional S.A. , Barcelona, Spain Vivia Biotech S.L....
Read More
BioCentury | Oct 15, 2012
Company News

Vivia Biotech management update

Vivia Biotech S.L. , Madrid, Spain Business: Cancer, Endocrine/Metabolic, Autoimmune Hired: Ferran Prat as COO of Vivia's personalized medicine division; formerly a VP of global marketing, corporate business development and global services at Dako A/S , which...
Read More
BioCentury | Apr 23, 2012
Financial News

Vivia Biotech completes venture financing

Vivia Biotech S.L. , Madrid, Spain Business: Cancer, Endocrine/Metabolic, Autoimmune Date completed: 4/16/12 Type: Venture financing Raised: €1.3 million ($1.6 million) Investor: Bioanalitica Inversiones WIR Staff autoimmune cancer...
Read More
BioCentury | Apr 23, 2012
Financial News

Vivia Biotech completes venture financing

Vivia Biotech S.L. , Madrid, Spain Business: Cancer, Endocrine/Metabolic, Autoimmune Date completed: 4/16/12 Type: Venture financing Raised: €6 million ($7.8 million) Investor: Multiinstrument JEREMIE Fund WIR Staff autoimmune cancer...
Read More
BioCentury | Apr 17, 2012
Financial News

Vivia receives loans, equity totaling EUR 7.2 million

...Cancer company Vivia Biotech S.L. (Madrid, Spain) received EUR 6 million ($7.8 million) in loans from the Multiinstrument...
Read More
Items per page:
1 - 5 of 5
BioCentury | Dec 17, 2012
Company News

Ferrer, Vivia Biotech deal

...developed under the deal, declined to disclose details. Grupo Ferrer Internacional S.A. , Barcelona, Spain Vivia Biotech S.L....
Read More
BioCentury | Oct 15, 2012
Company News

Vivia Biotech management update

Vivia Biotech S.L. , Madrid, Spain Business: Cancer, Endocrine/Metabolic, Autoimmune Hired: Ferran Prat as COO of Vivia's personalized medicine division; formerly a VP of global marketing, corporate business development and global services at Dako A/S , which...
Read More
BioCentury | Apr 23, 2012
Financial News

Vivia Biotech completes venture financing

Vivia Biotech S.L. , Madrid, Spain Business: Cancer, Endocrine/Metabolic, Autoimmune Date completed: 4/16/12 Type: Venture financing Raised: €1.3 million ($1.6 million) Investor: Bioanalitica Inversiones WIR Staff autoimmune cancer...
Read More
BioCentury | Apr 23, 2012
Financial News

Vivia Biotech completes venture financing

Vivia Biotech S.L. , Madrid, Spain Business: Cancer, Endocrine/Metabolic, Autoimmune Date completed: 4/16/12 Type: Venture financing Raised: €6 million ($7.8 million) Investor: Multiinstrument JEREMIE Fund WIR Staff autoimmune cancer...
Read More
BioCentury | Apr 17, 2012
Financial News

Vivia receives loans, equity totaling EUR 7.2 million

...Cancer company Vivia Biotech S.L. (Madrid, Spain) received EUR 6 million ($7.8 million) in loans from the Multiinstrument...
Read More
Items per page:
1 - 5 of 5